- Steven Reid, clinical research fellow (steve.reid@kcl.ac.uk),
- Trudie Chalder, senior lecturer,
- Anthony Cleare, senior lecturer,
- Matthew Hotopf, senior lecturer,
- Simon Wessely, professor of epidemiological and liaison psychiatry
- Guy's, Kings, and St Thomas's School of Medicine and Institute of Psychiatry, London SE5 8AZ
- Correspondence to: S Reid
Background
Definition Chronic fatigue syndrome is characterised by severe, disabling fatigue and other symptoms, including musculoskeletal pain, sleep disturbance, impaired concentration, and headaches. Two widely used definitions of chronic fatigue syndrome (from the US Centers for Disease Control and Prevention1 and from Oxford2—see table) were developed as operational criteria for research. There are two important differences between these definitions. The British criteria insist on the presence of mental fatigue; the American criteria include a requirement for several physical symptoms, reflecting the belief that chronic fatigue syndrome has an underlying immunological or infective pathology.
Interventions
Beneficial:
Exercise
Cognitive behavioural therapy
Unknown effectiveness:
Corticosteroids
Antidepressants
Dietary supplements
Oral nicotinamide adenine dinucleotide (NADH)
Unknown effectiveness:
Immunotherapy
Likely to be ineffective or harmful:
Prolonged rest
This review is one of 87 chapters from the second issue of Clinical Evidence www.evidence.com/
- In this window
- In a new window
Diagnostic criteria for chronic fatigue syndrome
Incidence/prevalence Community and primary care based studies have reported the prevalence of chronic fatigue syndrome to be 0.2-2.6%, depending on the criteria used.3 4 Systematic population surveys have found similar rates of the syndrome in people of different socioeconomic status, and in all ethnic groups.4 5 Female sex is the only demographic risk factor (relative risk 1.3 to 1.7 depending on diagnostic criteria used).6
Aetiology The cause of chronic fatigue syndrome is poorly understood.
Prognosis Studies of prognosis in chronic fatigue syndrome have focused on people attending specialist clinics, who are likely to have had the condition for longer and to have a poorer outlook. Children with the syndrome seem to have a notably better outcome:54-94% of children show definite improvement (after up to six years' follow up); 20-50% of adults show some improvement in the medium term and only 6% return to premorbid levels of functioning.7 Despite the considerable burden of morbidity associated with chronic fatigue syndrome, there is no evidence of increased …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Evidence Based Medicine-Boondoggle?
Published 8 February 2012
Wills and wishes in organ donation
Published 8 February 2012
Re: Lessons from America
Published 8 February 2012
Boosting the role of low-molecular-weight heparins in primary PCI
Published 8 February 2012
Re: Should UK membership exams be held overseas? Yes
Published 8 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Wakefield sues BMJ over MMR articles (5 responses)
Published 10 Jan 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012
How much of a social media profile can doctors have? (5 responses)
Published 23 Jan 2012